Connect with us

BIOTECH

Biotech On Track To Develop Bio-Synthetic Cannabinoids

Published

on

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) released news Sept 25, 2017 revealing that the company had made breakthroughs in the scale-up and commercialization of the biosynthesis process for cannabinoid production.

IN/IMLFF noted that it can selectively produce all four “gateway” cannabinoids using genetically engineered microorganisms.   InMed President, Eric Adams, explained that through synthesis, IN/IMLFF could produce a variety of cannabinoids economically, which opens the door for new products.

Adams further noted that InMed was “dedicating substantial resources” to the commercialization of biosynthetic cannabinoid products.

Financials Trend began covering InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) following its news on Sept 19, 2017, after announcing the filing of patents on biosynthesis of cannabinoids.  At the time we published that story, shares of InMed Pharmaceuticals rose 7% to $0.36.  Now, IN/IMLFF is trading at nearly $0.45.

We noted in our IN/IMLFF story that it was [BIG NEWS to the scientific community], but Mr. Adams clarified that further in yesterday’s press release when he explained how some extracts from marijuana are expensive to produce but through biosynthesis synthetic cannabinoids are just the opposite.

“The biosynthesis process opens up access to drug discovery and therapeutic use of all 90+ cannabinoids, most of which occur in only trace amounts in the plant and cannot be extracted in an economical fashion,” said Adams.

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) shares are trading up over 100% since Financials Trend first covered the company.  In that first article, we called InMed Pharmaceutical a “Five Bagger”, noting its gateway price of $0.21 at the time IN/IMLFF announced its patent applications and so far, it’s not disappointing our readers.  Our outlook hasn’t changed, yet we still stress patience in following IN/IMLFF progress.

 

Advertisement src="//cdn.bannersnack.com/iframe/embed.js">
Advertisement
Advertisement

Title

INDUSTRIAL HEMP3 months ago

Near-Term Headwinds Hit Scotts Miracle-Gro Co (NYSE:SMG) With A Huge Impact

Bank of America Corp (NYSE:BAC) has disclosed that Scotts Miracle-Gro Co (NYSE:SMG) has lately been experiencing several near term risks....

INDUSTRIAL HEMP3 months ago

Argitek Holdings Inc (OTCMKTS:AGTK) To Focus On Acquisition, Revenues & Profitability In 2018

Argitek Holdings Inc (OTCMKTS:AGTK) recently revealed that in 2018, the company’s main focus will be the acquisition, revenues, and profitability....

INDUSTRIAL HEMP3 months ago

PharmaCyte Biotech Inc (OTCMKTS:PMCB) Completes Pore Size Studies & 29 Tests Useful In Pancreatic Cancer Therapy

PharmaCyte Biotech Inc (OTCMKTS:PMCB) has said that the cells it is planning to use in the clinical trial in patients...

INDUSTRIAL HEMP3 months ago

Puration Inc (OTCMKTS:PURA) To Apply For Canadian Recreational Cannabis Cultivation License; To Give EVERx CBD Sports Water Free Samples

Puration Inc (OTCMKTS:PURA) recently announced that it will be applying for the Canadian recreational cannabis cultivation license. The confirmation came...

INDUSTRIAL HEMP3 months ago

Marijuana Company Of America Inc (OTCMKTS:MCOA)’s JV Completes 10,000 Sq. Ft. Greenhouse Set up; Provides Update on Oregon Project

Marijuana Company Of America Inc (OTCMKTS:MCOA) recently announced that its Joint Venture with Bougainville Ventures Inc. based in Washington has...

INDUSTRIAL HEMP3 months ago

Lifestyle Delivery Systems Inc.(OTCMKTS:LDSYF)’s CSPA Group Inc. Receives 15000 Reveur Units & 300 Liters Distillates’ Purchase Orders In Two Different Deals

Lifestyle Delivery Systems Inc. (OTCMKTS:LDSYF) recently made two big announcements related to the receipt of two open purchase orders to...

INDUSTRIAL HEMP3 months ago

Viaderma Inc (OTCMKTS:VDRM) Provides Update On Its Flagship Product Vitastem; Signs $250,000 Agreement With Vage Nigeria Ltd.

Viaderma Inc (OTCMKTS:VDRM), a publicly traded specialty pharmaceutical company recently announced an update on the sales of its flagship product...

INDUSTRIAL HEMP3 months ago

Plandai Biotechnology Inc (OTCMKTS:PLPL) Phytofare Gaining Traction in International Markets

Plandai Biotechnology Inc (OTCMKTS:PLPL) recently issued an update following the successful launch of its Phytofare® supplement. Plandai Biotechnology is a...

INDUSTRIAL HEMP3 months ago

MassRoots Inc (OTCMKTS:MSRT) Issues 2018 Annual Shareholder Letter

MassRoots Inc (OTCMKTS:MSRT) has issued its 2018 Annual Shareholder Letter highlighting on its recent developments as well as its plans...

INDUSTRIAL HEMP3 months ago

Players Network (OTCMKTS:PNTV) Signs Binding Letter Of Intent To Acquire A 56,000-Square-Foot, Fully Operating Greenhouse Complex

Players Network (OTCMKTS:PNTV), a leading integrated and diversified cannabis holding company has announced that it has signed a binding Letter...

Advertisement
Advertisement
Advertisement